U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. lowered its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 16.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 114,178 shares of the company’s stock after selling 22,550 shares during the quarter. Ameriprise Financial Inc. owned about 0.76% of U.S. Physical Therapy worth $10,129,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of USPH. Bahl & Gaynor Inc. raised its stake in shares of U.S. Physical Therapy by 135.4% in the 4th quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock valued at $23,076,000 after acquiring an additional 149,622 shares during the period. Copeland Capital Management LLC increased its holdings in U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after purchasing an additional 72,715 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in U.S. Physical Therapy in the fourth quarter valued at approximately $6,240,000. Envestnet Asset Management Inc. lifted its stake in U.S. Physical Therapy by 20.1% during the fourth quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company’s stock worth $26,594,000 after purchasing an additional 50,163 shares in the last quarter. Finally, Proficio Capital Partners LLC acquired a new position in U.S. Physical Therapy during the fourth quarter worth $3,526,000.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $79.81 on Tuesday. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $107.09. The stock has a market capitalization of $1.21 billion, a PE ratio of 84.90, a PEG ratio of 3.54 and a beta of 1.44. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The stock has a 50-day simple moving average of $71.89 and a 200-day simple moving average of $83.56.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm had revenue of $183.79 million for the quarter, compared to analysts’ expectations of $176.78 million. During the same quarter last year, the company earned $0.51 earnings per share. The firm’s revenue was up 18.0% compared to the same quarter last year. On average, analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 23rd will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.26%. The ex-dividend date of this dividend is Friday, May 23rd. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 82.57%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. JMP Securities reiterated a “market outperform” rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Barrington Research cut their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 8th. JPMorgan Chase & Co. dropped their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, March 19th. Finally, William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and a consensus target price of $109.00.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.00% of the stock is owned by insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.